Allergies and asthma are a continuing health problem in most developed countries, but just how do these ailments develop over the course of a childhood? In a population-based study designed to help answer this question, researchers in Norway found that 40 per cent — or two of five — of nearly 5,000 two-year-olds had [...]
CONCLUSIONS: In this cohort, having chronic rhinitis, having asthma that is more severe and having a low level of education were the main risk factors for ER visits due to asthma exacerbations. These results are similar to those reported for asthma patients who are receiving no regular treatment. (Source: Jornal Brasileiro de Pneumologia)
The objective of this study was to identify genes and polymorphisms associated with different wheezing phenotypes. Using data obtained from the Genetic Association Database, we systematically reviewed studies on genes and polymorphisms that have been associated with virus-induced wheezing or atopic asthma. The research was carried out in February of 2009. Genes associated with the [...]
A aspergilose é uma doença multifacetada cujas manifestações clínicas são determinadas pela resposta imune do hospedeiro; podem se apresentar de forma alérgica, saprofítica ou invasiva. A aspergilose broncopulmonar alérgica caracteriza-se por asma corticoide dependente, febre, hemoptise e destruição da via aérea, que pode progredir para fibrose com faveolamento. O tratamento consiste da associação de corticosteroide [...]
WHO spokesman, Gregory Hartl, said in a new briefing that the H1N1 flu pandemic (swine flu) continues to spread in parts of eastern and southeastern Europe, parts of Asia, and North Africa. However, he added that globally it is generally declining. The H1N1 pandemic virus continues to be the main influenza virus circulating globally. WHO [...]
MedImmune announced that clinical results of its pivotal multinational, randomized, double-masked trial for motavizumab have been published in the current issue of the peer-reviewed publication, Pediatrics: Official Journal of the American Academy of Pediatrics. Motavizumab is an investigational monoclonal antibody (MAb) being evaluated by the FDA for its potential to prevent serious disease caused by [...]
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental biologics license application (sBLA) for licensure of Fluzone® High-Dose (Influenza Virus Vaccine). The new vaccine, for adults 65 years of age and older, will be available to [...]
MedImmune announced that clinical results of its pivotal multinational, randomized, double-masked trial for motavizumab have been published in the current issue of the peer-reviewed publication, Pediatrics: Official Journal of the American Academy of Pediatrics… (Source: Infectious Diseases / Bacteria / Viruses News From Medical News Today)
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental biologics license application (sBLA) for licensure of Fluzone® High-Dose (Influenza Virus Vaccine)… (Source: Infectious Diseases / Bacteria / Viruses News From Medical News Today)
This article continues our 15-part article series called Heal Yourself in 15 Days. In part one, we looked at why the real secret to rapid healing is to remove the barriers to healing (http://www.naturalnews.com/028053_self_healing_quality_of_life.html). In part two, we look at why your healing potential is so powerful that you can’t even turn it off!When you [...]
